Compounds > nalmefene

nalmefene and taurine

nalmefene has been researched along with taurine in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (15.79)	18.2507
2000's	4 (21.05)	29.6817
2010's	12 (63.16)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Faden, AI; Graham, SH; Newman, A; Shimizu, H; Weinstein, P	1
Litten, RZ	1
Carey, TS; Crews, FT; Garbutt, JC; Lohr, KN; West, SL	1
Brady, KT; Malcolm, R; Myrick, H	1
Anton, RF	1
Salaspuro, M	1
Rösner, S; Soyka, M	1
Lumbad, J; Yancey, JR	1
Spanagel, R; Vengeliene, V	1
Franck, J; Jayaram-Lindström, N	1
Heinz, A; Müller, CA	1
Amick, HR; Bobashev, G; Feltner, C; Garbutt, JC; Gass, CE; Jonas, DE; Kim, MM; Rowe, CJ; Shanahan, E; Thomas, K; Wines, R	1
Borro, P; Leone, S; Testino, G	1
Lieb, M; Soyka, M	1
Agabio, R; Franconi, F; Gessa, GL; Pani, PP; Preti, A	1
Higuchi, S; Yumoto, Y	1
Bramness, JG; Mann, K; Wurst, FM	1
Goh, ET; Morgan, MY	1
Lyon, J	1

Reviews

15 review(s) available for nalmefene and taurine

Article	Year
Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA, 1999, Apr-14, Volume: 281, Issue:14 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Lithium; Naltrexone; Narcotic Antagonists; Serotonin Agents; Taurine	1999
New developments in the pharmacotherapy of alcohol dependence. The American journal on addictions, 2001, Volume: 10, Issue:s1 Topics: Acamprosate; Adjuvants, Anesthesia; Alcohol Deterrents; Alcoholism; Anticonvulsants; Buspirone; Carbamazepine; Drug Therapy; Ethanol; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Ritanserin; Serotonin Agents; Sodium Oxybate; Substance Withdrawal Syndrome; Taurine; Valproic Acid; Vigabatrin	2001
Pharmacologic approaches to the management of alcoholism. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 20 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior, Addictive; Clinical Trials as Topic; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome	2001
[Drug therapy of alcohol dependence--a critical review]. Duodecim; laaketieteellinen aikakauskirja, 2003, Volume: 119, Issue:24 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Anticonvulsants; Fructose; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Taurine; Topiramate	2003
Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review. Current drug abuse reviews, 2008, Volume: 1, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Delayed-Action Preparations; Dopamine; Drug Therapy, Combination; Humans; Motivation; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Receptors, Opioid; Secondary Prevention; Taurine; Temperance; Ventral Tegmental Area	2008
Opioid antagonists for the treatment of alcohol dependence. American family physician, 2011, Nov-01, Volume: 84, Issue:9 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Motivation; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Secondary Prevention; Taurine; Treatment Outcome	2011
New pharmacological treatment strategies for relapse prevention. Current topics in behavioral neurosciences, 2013, Volume: 13 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Animals; Disulfiram; Drugs, Investigational; History, 18th Century; History, 21st Century; Humans; Naltrexone; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Taurine	2013
Pharmacotherapy for alcohol dependence: status of current treatments. Current opinion in neurobiology, 2013, Volume: 23, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Disulfiram; Humans; Multicenter Studies as Topic; Naltrexone; Narcotic Antagonists; Taurine	2013
[New treatment options for alcohol dependence]. MMW Fortschritte der Medizin, 2013, May-02, Volume: 155, Issue:8 Topics: Acamprosate; Alcoholism; Baclofen; Combined Modality Therapy; Ethanol; Fructose; Humans; Naltrexone; Psychotherapy; Secondary Prevention; Socioenvironmental Therapy; Substance Withdrawal Syndrome; Taurine; Topiramate	2013
Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA, 2014, May-14, Volume: 311, Issue:18 Topics: Acamprosate; Alcohol-Related Disorders; Fructose; Harm Reduction; Humans; Naltrexone; Outpatients; Randomized Controlled Trials as Topic; Taurine; Topiramate	2014
Treatment of alcohol dependence: recent progress and reduction of consumption. Minerva medica, 2014, Volume: 105, Issue:6 Topics: Acamprosate; Age of Onset; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Binge Drinking; Contraindications; Craving; Disulfiram; Drugs, Investigational; Europe; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Naltrexone; Neurotransmitter Agents; Randomized Controlled Trials as Topic; Sodium Oxybate; Taurine	2014
Recent Developments in Pharmacotherapy of Alcoholism. Pharmacopsychiatry, 2015, Volume: 48, Issue:4-5 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Anticonvulsants; Baclofen; Humans; Naltrexone; Narcotic Antagonists; Pharmacogenetics; Randomized Controlled Trials as Topic; Taurine; Varenicline	2015
Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review. European addiction research, 2016, Volume: 22, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol Withdrawal Delirium; Alcoholism; Anticonvulsants; Benzodiazepines; Disulfiram; Female; Humans; Male; Naltrexone; Sex Factors; Taurine; Treatment Outcome	2016
[Pharmacological therapies for alcohol use disorder in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73, Issue:9 Topics: Acamprosate; Alcohol-Related Disorders; Alcohols; Humans; Japan; Naltrexone; Substance Withdrawal Syndrome; Taurine	2015
Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:7 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Baclofen; Disulfiram; Drug Combinations; Fructose; Humans; Naltrexone; Polymorphism, Single Nucleotide; Pyridoxine; Pyrrolidonecarboxylic Acid; Taurine; Topiramate; Treatment Outcome	2017

Other Studies

4 other study(ies) available for nalmefene and taurine

Article	Year
Opioid receptor antagonist nalmefene stereospecifically inhibits glutamate release during global cerebral ischemia. Brain research, 1993, Dec-31, Volume: 632, Issue:1-2 Topics: Animals; Aspartic Acid; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glycine; Hippocampus; Ischemic Attack, Transient; Kinetics; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reperfusion; Stereoisomerism; Taurine; Time Factors	1993
International update: new findings on promising medications. Alcoholism, clinical and experimental research, 1996, Volume: 20, Issue:8 Suppl Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Clinical Trials as Topic; Cocaine; Comorbidity; Europe; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Taurine; United States	1996
Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe. European addiction research, 2016, Volume: 22, Issue:6 Topics: Acamprosate; Alcohol Abstinence; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Europe; Humans; Marketing; Naltrexone; Narcotic Antagonists; Perception; Practice Guidelines as Topic; Societies, Medical; Surveys and Questionnaires; Taurine; Treatment Outcome	2016
More Treatments on Deck for Alcohol Use Disorder. JAMA, 2017, Jun-13, Volume: 317, Issue:22 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Amines; Baclofen; Cyclohexanecarboxylic Acids; Cytidine Diphosphate Choline; Disulfiram; Drug Repositioning; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Mifepristone; Naltrexone; National Institute on Alcohol Abuse and Alcoholism (U.S.); Off-Label Use; Patient Acceptance of Health Care; Taurine; Topiramate; United States; Varenicline	2017